Category Archives: Uncategorized

Earlier today, the MAPRx Coalition and 38 health advocacy organizations sent a letter to Health and Human Services (HHS) Secretary Designee Xavier Becerra in opposition to recent proposed changes to Medicare Part D, including the longstanding six protected classes policy.

The changes, announced on January 19...

The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2020 – December 7, 2020 for coverage beginning January 1, 2021. Plans make changes to benefits and costs, and there are also new plans in many areas of the country. Changes to the Part D benefit as a whole...

Earlier today, the MAPRx Coalition and 28 of its members, representing national patient, caregiver, and healthcare provider organizations, submitted comments to the Centers for Medicare and Medicaid Services (CMS) on their latest rule. Over the past 15 years, the Medicare Part D program has provided a critical avenue for beneficiaries to access prescription drugs. Its success...

Earlier today, the Medicare Access for Patients Rx Coalition (MAPRx) provided the Centers for Medicare & Medicaid Services (CMS) with our official commentary in response to the Advance Notice of Methodological Changes for Calendar Year 2021 for Medicare Advantage Capitation Rates and Part C and Part D Payment Policies – Part II released on February...

Earlier today, the Medicare Access for Patients Rx (MAPRx) Coalition submitted a letter, signed by 33 member organizations, to Senators Bill Cassidy and Bob Menendez in support of their legislation to address out-of-pocket (OOP) costs for Medicare Part D beneficiaries. S. 2911, the Seniors Prescription Drug Relief Act of 2019, includes a much-needed smoothing mechanism...

Earlier today, the Medicare Access for Patients Rx (MAPRx) Coalition submitted a letter, signed by 33 member organizations, to Congressional leadership urging them to take action to address the looming increase in out-of-pocket (OOP) costs Medicare Part D beneficiaries will incur this year. This increase, known as the "OOP Cliff," is due to the OOP...

Earlier today, the MAPRx Coalition submitted feedback and comments on Title III of H.R. 3, the Lower Drug Costs Now Act of 2019, to the Chairs and Ranking Members of the House of Representatives' Ways & Means, Energy & Commerce, and Education & Labor Committees. The Coalition appreciates the House's leadership in advancing policy to cap out-of-pocket...

The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2019 – December 7, 2019 for coverage beginning January 1, 2020. Plans make changes to benefits and costs, and there are also new plans in many areas of the country. Changes to the Part D benefit as a whole may also...

Today, the MAPRx Coalition and 28 of its members, national organizations representing patients, caregivers, and healthcare professionals, submitted a letter to the Senate Finance Committee on their recently released legislation, The 2019 Prescription Drug Pricing Reduction Act of 2019. The Coalition greatly appreciates the Committee's leadership in improving access to prescription drugs for the more than 44...

On June 6, MAPRx and 45 national advocacy organizations submitted a letter to leadership in the House of Representatives' Ways and Means Committee and Energy and Commerce Committee with recommendations for improving Medicare Part D. Among other improvements, the letter made clear that the MAPRx Coalition supports a cap on out-of-pocket spending for the more...